Sanofi Proceeds From Borrowings Classified As Financing Activities
Sanofi (SNY) reported Proceeds From Borrowings Classified As Financing Activities of EUR 5.56 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities · last filed 2026-02-17
| Period end | Proceeds From Borrowings Classified As Financing Activities 12 month |
|---|---|
| 2025-12-31 | 5.56B EUR 20-F · filed 2026-02-17 |
| 2024-12-31 | 0.00 EUR 20-F · filed 2026-02-17 |
| 2023-12-31 | 48.00M EUR 20-F · filed 2026-02-17 |
| 2022-12-31 | 1.55B EUR 20-F · filed 2025-02-13 |
| 2021-12-31 | 0.00 EUR 20-F · filed 2024-02-23 |
| 2020-12-31 | 2.02B EUR 20-F · filed 2023-02-24 |
| 2019-12-31 | 2.00B EUR 20-F · filed 2022-02-23 |
| 2018-12-31 | 9.68B EUR 20-F · filed 2019-03-08 |
| 2017-12-31 | 41.00M EUR 20-F/A · filed 2018-03-16 |